Shanghai Fosun Pharmaceutical Co., Ltd., Ten Percent Owner at Nature's Sunshine Products, holds 64.17K shares in Nature's Sunshine Products (Ticker: NATR), holds 7.90M shares in ContraFect (Ticker: CFRXQ). Most recently, Shanghai Fosun Pharmaceutical Co., Ltd. Sold ― shares of Nature's Sunshine Products on Jun 27, 2025 for an estimated value of 32.71M.
What was Shanghai Fosun Pharmaceutical Co., Ltd.’s latest transaction?
Shanghai Fosun Pharmaceutical Co., Ltd. latest transaction was an Informative Sell of $32.71M.
What was Shanghai Fosun Pharmaceutical Co., Ltd.'s most profitable transaction?
Shanghai Fosun Pharmaceutical Co., Ltd.’s most profitable transaction was an Informative Sell of CFRXQ stock on December 6, 2018. The return on the trade was 84.60%.
What is Shanghai Fosun Pharmaceutical Co., Ltd.'s role in Nature's Sunshine Products?
Shanghai Fosun Pharmaceutical Co., Ltd.'s role in Nature's Sunshine Products is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.